Britain cleared the $110 billion Paramount-Warner deal. A March 2027 trial now sets the timeline.

The UK Competition and Markets Authority cleared Paramount Skydance Corporation's anticipated acquisition of Warner Bros. Discovery at Phase 1 on 6 August 2026, declining to refer the deal for a deeper Phase 2 investigation. The CMA concluded the merger raised no competition concerns in the UK market. The clearance adds the United Kingdom to a list that now spans 66 jurisdictions, including the United States, the European Commission, Australia, Brazil, Canada, China, South Africa and South Korea, where authorities have either approved the transaction or declined to challenge it.

The CMA's reasoning is worth examining for anyone tracking how regulators are framing studio consolidation. Although Paramount and Warner Bros. Discovery compete closely in film and television distribution, the regulator found they are not closer competitors to each other than either is to Universal, Disney, or Sony. The merged entity would become the largest distributor in the UK but would still face those three majors plus a range of smaller studios. On streaming, the CMA determined that Netflix, Apple, Disney, Amazon Prime, and broadcaster video-on-demand services including BBC iPlayer and ITVX would collectively provide sufficient competitive pressure.

Litigation, not regulation, is now the binding constraint

Despite a near-sweep of global regulatory approvals, the deal cannot close. A coalition of 12 state attorneys general, led by California Attorney General Rob Bonta, sued on 13 July 2026 to block the merger. Their complaint argues the combination would remove competition in wide-release theatrical distribution, top-grossing film releases, and basic cable channel licensing. The Writers Guild of America filed a separate suit contending the merger would reduce the number of buyers for scripts and worsen terms for writers. Paramount Skydance has agreed not to close the acquisition before 1 June 2027, or shortly after the merits of those suits are resolved.

A filing in the US District Court for the Northern District of California set trial for 2 March 2027, with proceedings expected to run approximately 12 court days and conclude by 19 March 2027. That schedule makes the trial, not any remaining regulatory process, the event that determines when the approximately $110 billion transaction can actually change hands. The US Department of Justice cleared the deal in mid-June without conditions or required divestitures, which means the antitrust risk left in the deal sits entirely with the state-level litigation.

What the timeline means for media buyers and studio supply chains

For organizations that buy media, license content, or sell into studio supply chains, the practical implication is a defined waiting period rather than open-ended uncertainty. The trial window in March 2027 sets a hard checkpoint. A ruling in favor of the merged company could allow closing as early as late March or April 2027, with the June 2027 standstill serving as the outer bound. A ruling against the transaction would reopen the deal's structure entirely, with outcomes ranging from a negotiated remedy to an unwinding.

In the interim, both Paramount Skydance and Warner Bros. Discovery continue to operate as separate entities, each making content acquisition, distribution, and licensing decisions independently. Counterparties negotiating multi-year agreements with either studio should account for the possibility that ownership, brand strategy, and procurement priorities could shift meaningfully after a closing. The attorneys general's core concern, that consolidation reduces competition in theatrical distribution and cable licensing, is also a signal about which market segments are most likely to see structural changes post-close if the deal proceeds.

David Ellison leads Paramount Skydance, and the combined company, if the litigation is resolved in its favor, would represent a significant reshaping of the studio landscape. With global regulators largely satisfied and a specific trial date on the calendar, the deal has moved from a question of whether it can happen to a question of when, and on what terms the courts will allow it.